Pfizer's managing director S Sridhar to take an early retirement

Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years

Pfizer to acquire oncology specialist Medivation for $ 14 bn
Press Trust of India New Delhi
1 min read Last Updated : Aug 11 2022 | 12:00 AM IST

Drug firm Pfizer on Wednesday said its Managing Director S Sridhar has resigned from the company.

Sridhar has expressed his intention to take early retirement and has tendered his resignation, the company said in a regulatory filing.

He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, it added.

Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years.

Over the past six years, he has led Pfizer as Managing Director and made significant contributions to the growth of the company's portfolio and presence across India, the drug firm stated.

Sridhar also serves as the President of the Organisation of Pharmaceuticals Producers of India (OPPI).

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PfizerPharma CompaniesPfizer India

First Published: Aug 11 2022 | 12:00 AM IST

Next Story